Rapid-Acting Insulin Market Expected to Reach $11.17 billion by 2032 | 2024 Research Report
September 09, 2024 09:22 ET
|
Research and Markets
Dublin, Sept. 09, 2024 (GLOBE NEWSWIRE) -- The "Rapid Acting Insulin Market Report, Forecast by Product, Indication, Distribution Channel, Countries and Company Analysis 2024-2032" report has been...
Insights on the Rapid Acting Insulin Global Market to 2027 - by Product, Indication, Distribution Channel and Region
August 22, 2022 08:43 ET
|
Research and Markets
Dublin, Aug. 22, 2022 (GLOBE NEWSWIRE) -- The "Rapid Acting Insulin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...
United States $46 Billion Biosimilar Insulin Market Opportunity & Clinical Trials Forecasts to 2026
August 27, 2021 06:13 ET
|
Research and Markets
Dublin, Aug. 27, 2021 (GLOBE NEWSWIRE) -- The "US Biosimilar Insulin Market Opportunity & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.com's offering. The US...
Insights on the Rapid Acting Insulin Global Market to 2027 - by Product Type, Indication, Distribution Channel and Regional Outlook
July 22, 2021 07:38 ET
|
Research and Markets
Dublin, July 22, 2021 (GLOBE NEWSWIRE) -- The "Global Rapid Acting Insulin Market By Product Type, By Indication, By Distribution Channel, By Regional Outlook, Industry Analysis Report and Forecast,...
Global Rapid Acting Insulin Market (2020 to 2027) - by Product Type, Indication, and Distribution Channel
June 01, 2021 05:28 ET
|
Research and Markets
Dublin, June 01, 2021 (GLOBE NEWSWIRE) -- The "Rapid Acting Insulin Market by Product Type, Indication, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2020-2027" report...
China Recombinant Lispro Insulin Markets, 2016-2020 & 2021-2025
April 23, 2021 06:53 ET
|
Research and Markets
Dublin, April 23, 2021 (GLOBE NEWSWIRE) -- The "Investigation Report on China's Recombinant Lispro Insulin Market, 2021-2025" report has been added to ResearchAndMarkets.com's offering. By the end...